Important role of oxidative stress biomarkers in Huntington's disease

Isaac Túnez1, Fernando Sánchez-López, Eduardo Agüera

  • 1Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)/Universidad de Córdoba, Córdoba, Spain. fm2tufii@uco.es

Insights

Oxidative stress increases and antioxidant defenses decrease in Huntington's disease (HD) patients. These changes correlate with disease progression, highlighting oxidative stress's role in HD pathogenesis.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Pathology

Background:

  • Huntington's disease (HD) is a neurodegenerative disorder with complex pathophysiology.
  • Oxidative stress is implicated in various neurodegenerative conditions.

Purpose of the Study:

  • To investigate global oxidative stress (GOS) and antioxidant system status in HD patients.
  • To correlate these markers with the stage of HD progression.

Main Methods:

  • Analysis of oxidative stress biomarkers in HD patients.
  • Assessment of antioxidant system function.
  • Correlation analysis between GOS, antioxidant markers, and disease stage.

Main Results:

  • HD patients exhibited elevated oxidative stress biomarkers.
  • A significant reduction in antioxidant system function was observed in HD patients.
  • These alterations were more pronounced in earlier stages (HD1) compared to later stages (HD2).
  • Carbonylated proteins and GOS levels showed a positive correlation with disease stage.

Conclusions:

  • Oxidative stress is a key factor in the pathogenesis of Huntington's disease.
  • The findings suggest potential therapeutic targets related to modulating oxidative stress in HD.